Literature DB >> 29388468

PLCγ1-PKCε-IP3R1 signaling plays an important role in hypoxia-induced calcium response in pulmonary artery smooth muscle cells.

Vishal R Yadav1, Tengyao Song1, Lin Mei1, Leroy Joseph1, Yun-Min Zheng1, Yong-Xiao Wang1.   

Abstract

Hypoxia-induced pulmonary vasoconstriction (HPV) is attributed to an increase in intracellular Ca2+ concentration ([Ca2+]i) in pulmonary artery smooth muscle cells (PASMCs). We have reported that phospholipase C-γ1 (PLCγ1) plays a significant role in the hypoxia-induced increase in [Ca2+]i in PASMCs and attendant HPV. In this study, we intended to determine molecular mechanisms for hypoxic Ca2+ and contractile responses in PASMCs. Our data reveal that hypoxic vasoconstriction occurs in pulmonary arteries, but not in mesenteric arteries. Hypoxia caused a large increase in [Ca2+]i in PASMCs, which is diminished by the PLC inhibitor U73122 and not by its inactive analog U73433 . Hypoxia augments PLCγ1-dependent inositol 1,4,5-trisphosphate (IP3) generation. Exogenous ROS, hydrogen peroxide (H2O2), increases PLCγ1 phosphorylation at tyrosine-783 and IP3 production. IP3 receptor-1 (IP3R1) knock-down remarkably diminishes hypoxia- or H2O2-induced increase in [Ca2+]i. Hypoxia or H2O2 increases the activity of IP3Rs, which is significantly reduced in protein kinase C-ε (PKCε) knockout PASMCs. A higher PLCγ1 expression, activity, and basal [Ca2+]i are found in PASMCs, but not in mesenteric artery smooth muscle cells from mice exposed to chronic hypoxia (CH) for 21 days. CH enhances H2O2- and ATP-induced increase in [Ca2+]i in PASMCs and PLC-dependent, norepinephrine-evoked pulmonary vasoconstriction. In conclusion, acute hypoxia uniquely causes ROS-dependent PLCγ1 activation, IP3 production, PKCε activation, IP3R1 opening, Ca2+ release, and contraction in mouse PASMCs; CH enhances PASM PLCγ1 expression, activity, and function, playing an essential role in pulmonary hypertension in mice.

Entities:  

Keywords:  calcium; hypoxia; hypoxia-induced pulmonary vasoconstriction; inositol 1,4,5-trisphosphate receptor-1; phospholipase C-γ1; protein kinase C-ε; reactive oxygen species

Mesh:

Substances:

Year:  2018        PMID: 29388468      PMCID: PMC6008133          DOI: 10.1152/ajplung.00243.2017

Source DB:  PubMed          Journal:  Am J Physiol Lung Cell Mol Physiol        ISSN: 1040-0605            Impact factor:   5.464


  66 in total

Review 1.  Hydrogen peroxide--an intracellular signal in the pulmonary circulation: involvement in hypoxic pulmonary vasoconstriction.

Authors:  R D Jones; A H Morice
Journal:  Pharmacol Ther       Date:  2000-11       Impact factor: 12.310

Review 2.  Role for mitochondrial reactive oxygen species in hypoxic pulmonary vasoconstriction.

Authors:  Gregory B Waypa; Paul T Schumacker
Journal:  Novartis Found Symp       Date:  2006

Review 3.  The structural basis of pulmonary hypertension in chronic lung disease: remodelling, rarefaction or angiogenesis?

Authors:  Natalie Hopkins; Paul McLoughlin
Journal:  J Anat       Date:  2002-10       Impact factor: 2.610

Review 4.  Reactive oxygen species and RhoA signaling in vascular smooth muscle: role in chronic hypoxia-induced pulmonary hypertension.

Authors:  Thomas C Resta; Brad R S Broughton; Nikki L Jernigan
Journal:  Adv Exp Med Biol       Date:  2010       Impact factor: 2.622

5.  Role of mitochondrial reactive oxygen species in hypoxia-dependent increase in intracellular calcium in pulmonary artery myocytes.

Authors:  Qing-Song Wang; Yun-Min Zheng; Ling Dong; Ye-Shih Ho; Zhongmao Guo; Yong-Xiao Wang
Journal:  Free Radic Biol Med       Date:  2006-12-14       Impact factor: 7.376

Review 6.  Regulation of hypoxic pulmonary vasoconstriction: basic mechanisms.

Authors:  N Sommer; A Dietrich; R T Schermuly; H A Ghofrani; T Gudermann; R Schulz; W Seeger; F Grimminger; N Weissmann
Journal:  Eur Respir J       Date:  2008-12       Impact factor: 16.671

7.  Hypoxia enhances cellular proliferation and inositol 1,4, 5-triphosphate generation in fibroblasts from bovine pulmonary artery but not from mesenteric artery.

Authors:  D J Welsh; P Scott; R Plevin; R Wadsworth; A J Peacock
Journal:  Am J Respir Crit Care Med       Date:  1998-12       Impact factor: 21.405

8.  Enhanced depolarization-induced pulmonary vasoconstriction following chronic hypoxia requires EGFR-dependent activation of NAD(P)H oxidase 2.

Authors:  Charles E Norton; Brad R S Broughton; Nikki L Jernigan; Benjimen R Walker; Thomas C Resta
Journal:  Antioxid Redox Signal       Date:  2012-10-18       Impact factor: 8.401

9.  ET-1 activates Ca2+ sparks in PASMC: local Ca2+ signaling between inositol trisphosphate and ryanodine receptors.

Authors:  Wei-Min Zhang; Kay-Pong Yip; Mo-Jun Lin; Larissa A Shimoda; Wen-Hong Li; James S K Sham
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2003-05-09       Impact factor: 5.464

10.  Pulmonary arteries and veins in experimental hypoxia. An ultrastructural study.

Authors:  K P Dingemans; C A Wagenvoort
Journal:  Am J Pathol       Date:  1978-11       Impact factor: 4.307

View more
  13 in total

1.  Overview on Interactive Role of Inflammation, Reactive Oxygen Species, and Calcium Signaling in Asthma, COPD, and Pulmonary Hypertension.

Authors:  Lillian Truong; Yun-Min Zheng; Sharath Kandhi; Yong-Xiao Wang
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

2.  Important Role of Sarcoplasmic Reticulum Ca2+ Release via Ryanodine Receptor-2 Channel in Hypoxia-Induced Rieske Iron-Sulfur Protein-Mediated Mitochondrial Reactive Oxygen Species Generation in Pulmonary Artery Smooth Muscle Cells.

Authors:  Zhao Yang; Tengyao Song; Lillian Truong; Jorge Reyes-García; Lan Wang; Yun-Min Zheng; Yong-Xiao Wang
Journal:  Antioxid Redox Signal       Date:  2019-10-11       Impact factor: 8.401

3.  Rieske iron-sulfur protein induces FKBP12.6/RyR2 complex remodeling and subsequent pulmonary hypertension through NF-κB/cyclin D1 pathway.

Authors:  Lin Mei; Yun-Min Zheng; Tengyao Song; Vishal R Yadav; Leroy C Joseph; Lillian Truong; Sharath Kandhi; Margarida M Barroso; Hiroshi Takeshima; Marc A Judson; Yong-Xiao Wang
Journal:  Nat Commun       Date:  2020-07-15       Impact factor: 14.919

4.  IRAG1 Deficient Mice Develop PKG1β Dependent Pulmonary Hypertension.

Authors:  Siladitta Biswas; Baktybek Kojonazarov; Stefan Hadzic; Michael Majer; Ganimete Bajraktari; Tatyana Novoyatleva; Hossein Ardeschir Ghofrani; Friedrich Grimminger; Werner Seeger; Norbert Weissmann; Jens Schlossmann; Ralph Theo Schermuly
Journal:  Cells       Date:  2020-10-13       Impact factor: 6.600

5.  Isorhapontigenin ameliorates cerebral ischemia/reperfusion injury via modulating Kinase Cε/Nrf2/HO-1 signaling pathway.

Authors:  Zhe Xue; Kai Zhao; Zhenghui Sun; Chen Wu; Bowen Yu; Dongsheng Kong; Bainan Xu
Journal:  Brain Behav       Date:  2021-06-08       Impact factor: 2.708

Review 6.  Cellular mechanosignaling in pulmonary arterial hypertension.

Authors:  Ariel Wang; Daniela Valdez-Jasso
Journal:  Biophys Rev       Date:  2021-09-02

Review 7.  Hypoxia and the integrated stress response promote pulmonary hypertension and preeclampsia: Implications in drug development.

Authors:  Xiang-Qun Hu; Lubo Zhang
Journal:  Drug Discov Today       Date:  2021-07-22       Impact factor: 7.851

Review 8.  Structure and Function of Mitochondria-Associated Endoplasmic Reticulum Membranes (MAMs) and Their Role in Cardiovascular Diseases.

Authors:  Yi Luan; Ying Luan; Rui-Xia Yuan; Qi Feng; Xing Chen; Yang Yang
Journal:  Oxid Med Cell Longev       Date:  2021-07-11       Impact factor: 6.543

9.  Association between serum calcium and prognosis in patients with acute pulmonary embolism and the optimization of pulmonary embolism severity index.

Authors:  Xin Wang; Yongbo Xiang; Ting Zhang; Yuqing Yang; Xuefeng Sun; Juhong Shi
Journal:  Respir Res       Date:  2020-11-11

Review 10.  Important Functions and Molecular Mechanisms of Mitochondrial Redox Signaling in Pulmonary Hypertension.

Authors:  Jorge Reyes-García; Abril Carbajal-García; Annarita Di Mise; Yun-Min Zheng; Xiangdong Wang; Yong-Xiao Wang
Journal:  Antioxidants (Basel)       Date:  2022-02-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.